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ABSTRACT  
Objective: The objective of the present study is to determine the phenylhydrazine (PHZ) induced oxidative stress mediated alteration in the 
metabolic status and morphology of the red blood cells (RBC) and amelioration of the same by aqueous bark extract of Terminalia arjuna (TA).  
Methods: Fresh goat blood collected from local Kolkata Corporation approved slaughter house, was used for the present study. Packed cells were 
prepared from the freshly collected goat blood and were divided into four groups as follows for further studies i. e Group I: Control (CON), Group II: 
TA bark extract treated, named T5C (5 mg/ml, incubation mixture; positive control), Group III: PHZ treated (1 mM), Group IV: PHZ treated+TA bark 
extract at a dose of 5 mg/ml, named as P+T5. ROS, superoxide anion radical, and hydroxyl radical scavenging activity were determined. Intracellular 
iron and intracellular nitrate concentration were estimated. Activities of various membrane-bound enzymes like Na+/K+-ATPase, Mg2+-ATPase and 
Ca2+-ATPase and Ach-E were determined. Moreover, the activities of some metabolic enzymes like glucose 6-phosphate dehydrogenase (G6PDH), 
hexokinase, aldolase, lactase dehydrogenase were also studied. In addition, the morphological structure of RBCs was also determined.  
Results: PHZ treatment caused significant alterations in RBC morphology as well as altered the activities of membrane-bound as well as metabolic 
enzymes. All these changes following oxidative stress were found to be ameliorated when the RBCs were co-treated with PHZ and aqueous bark 
extract of TA. However, aqueous bark extract of TA alone did not exhibit any such changes in RBC. 
Conclusion: The aqueous bark extract of TA ameliorates PHZ-induced oxidative damages in goat RBC possibly by an antioxidant mechanism(s). The 
aqueous bark extract of TA may have future therapeutic relevance in oxidative stress-induced damages in RBCs. 
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INTRODUCTION 
Red blood cells (RBCs) are one of the most susceptible biological 
tissues to oxidative stress due to the presence of high concentration 
of polyunsaturated fatty acids (PUFA) in the membrane and the 
oxygen transport associated with redox active hemoglobin 
molecules, which are promoters of ROS. Due to their susceptibility to 
oxidation, RBC are often used as cellular models to investigate the 
oxidative damage.  
Phenylhydrazine (PHZ), one of the most investigated intracellular 
free radical generating probes promotes oxidative damage in 
erythrocytes. It can penetrate to the 02-binding site of the 
haemoglobin molecule and react with it. PHZ oxidation results in the 
formation of superoxide anion free radicals and hydrogen peroxide 
[1-4]. These ROS and intermediates of PHZ form complexes with 
haemoglobin [5-7] which can denature the hemoglobin molecule [8]. 
Iron is probably released from the denatured hemoglobin, which 
may promote the conversion of superoxide anion free radicals and 
hydrogen peroxide into the very reactive hydroxyl radical through 
the Haber-Weiss reaction [9]. 
Since there are no mitochondria in erythrocytes, these cells depend 
on less efficient pathways for production of high-energy compounds, 
the anaerobic glycolytic (Embden-Meyerhof) pathway, which is also 
known as the hexose monophosphate shunt or the phospho-
gluconate pathway. Under normal circumstances, about 90% of 
glucose entering the red cell is metabolized by the anaerobic 
pathway and 10% by the aerobic pathway [10]. It has been reported 
that G6PDH and other metabolic enzymes like hexokinase and 
aldolase activity is reduced, and LDH activity is increased following 
oxidative stress [10].  
Membrane-bound enzymes are important in maintaining the normal 
physiology of erythrocytes [11, 12 ]. Free-radicals induced 
degenerative changes in erythrocytes which disturbed the structural 
integrity of the membrane that in turn affected the activities of 
membrane-bound enzymes like Na+/K+-ATPase, Mg2+-ATPase and 
Ca2+-ATPase [11] and AchE [12] activity. The level of nitric oxide 
(NO), another oxidative stress biomarker also increased during 
conditions of oxidative stress. NO is responsible for the conversion 
of oxyhemoglobin to methemoglobin (MHb) [13]. Increased NO 
status also indicates the increased nitric oxide synthase (NOS) 
activity in the cell.  
Terminalia arjuna (TA) belonging to the family Combretaceae, is an 
important medicinal plant widely used in the preparation of 
Ayurvedic formulations for over three centuries in India. It is 
primarily used in the treatment of coronary artery diseases, heart 
failure and hypercholesterolemia [14-16]. It has also been found to 
have antibacterial and antimutagenic activities [17-19]. It has been 
earlier reported from this laboratory that aqueous bark extract of 
TA provides protection to RBCs against oxidative stress in vitro 
through antioxidant mechanisms [20]. 
The aim of our present study was to elucidate whether this aqueous 
bark extract of TA is capable of protecting the membrane-bound 
enzymes and the enzymes of the metabolic pathway of anaerobic 
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oxidation in goat RBCs from phenylhydrazine-induced oxidative 
stress in vitro and whether antioxidant mechanisms are associated 
with such protection. 
MATERIALS AND METHODS 
Chemicals used  
Powder of bark of Terminalia arjuna (TA) was purchased from 
Herby House, Kolkata India. All the other chemicals used including 
the solvents were of analytical grade obtained from Sisco Research 
Laboratories (SRL), Mumbai, India, Qualigens (India/Germany), SD 
fine chemicals (India), Merck Limited, Delhi, India. 
Preparation of aqueous extract from TA bark powder 
Five gm of TA bark powder was dissolved in 25 ml of double 
distilled water. After proper mixing it was kept with cotton plugging 
for overnight (approximately 16 h*). Then, it was centrifuged twice 
at 1300g for 10 min. The supernatant, thus obtained, was collected, 
frozen and lyophilized. The yield of the aqueous extract of TA from 5 
gm of TA bark powder was 10%. The lyophilized material herein 
was termed as aqueous bark extract. Different concentrations of the 
extract dissolved in double distilled water were used for the present 
study, and any leftover extract was always discarded.  
Processing of goat blood to obtain the whole RBCs 
Goat blood was collected from local Kolkata Corporation approved 
slaughterhouse in Acid Citrate Dextrose buffer. Packed RBCs were 
obtained by centrifugation at 3000rpm for 10 min at 4 °C. The plasma 
and the buffy coat were removed by aspiration and the whole RBCs, 
thus obtained, were washed thrice with 0.9% NaCl solution. 
In vitro incubation of whole RBCs with the PHZ and aqueous 
bark extract of TA 
The following experiments were carried out with whole RBCs 
divided into four groups. 
Group I: Control (CON) 
Group II: TA treated, named T5C (5 mg/ml, incubation mixture; 
positive control)  
Groups III: PHZ treated (PHZ) 
Group IV: PHZ treated+TA at a dose of 5 mg/ml, named as P+T5 
Five hundred µl of whole RBCs with 1 mM phenylhydrazine (PHZ), a 
concentration of 5 mg/ml of aqueous bark extract of TA and 50 mM 
sodium phosphate buffer (pH 7.4) in a final volume of 1.0 ml were 
incubated at 37 °C in a shaking water bath for 1 hour. The incubation 
was terminated by addition of 100μl of 16 mM EDTA and the treated 
red blood cells were washed thrice with 0.9% NaCl solution prior to 
lysis and preparation of membrane there from.  
Preparation of hemolysate from incubated whole RBCs for the 
assay of antioxidant enzymes 
For the assay of antioxidant enzymes, after lysis of the washed 
erythrocytes in deionized water, the suspension was centrifuged at 
7000 rpm. for 25 min at 4 °C. The supernatants, thus obtained, were 
then stored at–20 °C to be used later for the assay. 
Preparation of erythrocyte membrane 
Haemoglobin-free erythrocyte membrane (either control or treated) 
was prepared according to a method of Arduini et al. [34]. The washed 
erythrocytes were subjected to hypotonic lysis in 40 volumes of 5 mM 
sodium phosphate buffer (pH 8.0) and centrifuged at 14,000 rpm for 
20 min at 4 °C. The supernatant, thus obtained, was discarded and the 
pellet was washed at least five times in the same buffer until a 
colorless pellet was obtained. The erythrocyte ghosts were suspended 
in the same buffer and stored at–20 °C for future use.  
Determination of ROS scavenging activity of aqueous TA bark 
extract in a chemically defined system  
The RBCs were washed with phosphate-buffered saline (PBS) to 
remove traces of the original medium. Washed RBCs were incubated 
with 2´,7´–dichlorofluorescein diacetate (DCFDA) at a final 
concentration of 1μM and was kept 30 min in the dark, in a 
conventional incubator (37 °C, 5% CO2). The DCFDA containing 
medium was removed, and the RBCs were washed twice with PBS. 
The level of ROS was assessed immediately by flow cytometry [21].  
Hydroethidine (HE) was used as a superoxide indicator. HE is 
oxidized selectively by superoxide to ethidium, whose fluorescence 
intensity within the cell is proportional to the total production of 
superoxide anion free radicals [22]. The oxidation of HE is not 
accomplished by hydroxyl radical, singlet O2, H2O2 or nitrogen 
radicals.  
The hydroxyl (·OH) radical was generated in sodium phosphate 
buffer (0.05 mM, pH 7.4) with 1 mM PHZ for 60 min in the presence 
and absence of dimethyl sulfoxide (DMSO) (500μM) and different 
concentrations of aqueous bark extract of TA in a volume of 1 ml to 
determine the ·OH scavenging activity of the aqueous bark extract of 
TA in an in vitro system. The reaction was terminated in each case by 
the addition of 16 mM EDTA. Methane sulfonic acid (MSA) formed 
during incubation was measured by the method of Babbs and 
Steiner [23] as modified by Bandyopadhyay et al. [24] 
Estimation of iron content of RBCs by Atomic absorption 
spectrophotometry (AAS) 
The iron content of the RBCs was determined by atomic absorption 
spectrophotometry as per the protocol mentioned in the cookbook 
of the Sophisticated Analytical Instrument Facilities’ (SAIF) and 
‘‘Thermo Scientific mCE 3000 Series Atomic Absorption 
Spectrometer’’ available at the Chemical Engineering Department of 
University College of Science and Technology, University of Calcutta 
and at the Bose Institute, Kolkata. After in vitro incubation of whole 
RBCs, the cells were centrifuged at 3000 rpm for 10 min. The 
supernatant, thus obtained, was collected in a conical flask. 
Concentrated nitric acid was then carefully added to it and the 
conical flask with its contents was placed on the hot plate and 
heated at 65–70 °C for digestion of the RBCs and heated until white 
fumes come out. The contents of the conical flasks were then 
carefully and quantitatively transferred into 25 ml volumetric flasks, 
and, finally, the volume made up to 25 ml with double distilled 
water. The iron content of the samples was then measured using an 
atomic absorption spectrophotometer [25]. 
Measurement of the activities of glucose-6-phosphate 
dehydrogenase (G6PDH), hexokinase, aldolase and lactate 
dehydrogenase (LDH) of RBCs 
Glucose-6-phosphate dehydrogenase activity was determined in 
hemolysate by measuring the increase in absorbance 
spectrophotometrically at 340 nm. The reaction mixture containing 
0.006 M NADP and 0.1 M glucose-6-phosphate in 2.7 ml of 0.055 M 
Tris HCl buffer, pH7.8 with 0.0033M MgCl2were individually 
incubated for 7-8 min to reach temperature equilibrium and then 
hemolysate was added and the change in absorbance recorded at 
340 nm for 5 min [26]. The enzyme activity was expressed as 
units/minute/mg of protein. 
The activity of hexokinase was determined from RBC hemolysate by 
using 0.67 M glucose as the substrate, 0.05 M Tris Mgcl2 buffer (pH 
8), 16.5 mM ATP, 6.8 mM NAD and glucose 6 phosphate 
dehydrogenase (300 IU/ml of Tris MgCl2 buffer). The change in 
absorbance was observed spectrophotometrically at 340 nm [27]. 
The enzyme activity was expressed as units/minute/mg of protein. 
The activity of aldolase was measured in hemolysate based on the 
fact that 3-phosphoglyceraldehyde reacts with hydrazine to form a 
hydrazone which absorbs at 420 nm. The reagents used were 0.012 
M fructose-bis-phosphate, 0.1 mM EDTA containing 0.0035 M 
hydrazine sulphate, pH 7.5 and hemolysate as the source of the 
enzyme. The change in absorbance was recorded 
spectrophotometrically at 240 nm for 10 min [28]. The enzyme 
activity was expressed as units/minute/mg of protein. 
The activity of lactate dehydrogenase was determined 
spectrophotometrically by measuring the oxidation of NADH (0.1 
mM) to NAD+at 340 nm using 1.0 mM sodium pyruvate as a 
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substrate, according to the method Dhanesha et al. [29]. The enzyme 
activity was expressed as units/minute/mg of protein. 
Determination of the activities of sodium-potassium ATPase 
(Na+/K+ATPase), magnesium-ATPase (Mg2+ATPase) and calcium 
ATPase (Ca2+ATPase) in RBCs 
The activities of Na+/K+ATPase, Mg2+ATPase, and Ca2+ATPase, were 
determined simultaneously from the membrane fraction of RBCs. 
Na+/K+Mg2+ATPase activities were determined from the hemolysate 
in the presence of 180 µM EGTA; total ATPase activity was measured 
in the presence of calcium, and only Mg2+ATPase activity was 
determined in the presence of 180 µM EGTA and 0.5 mM ouabain. 
Mg2+ATPase activity was deducted from the combined activity of 
Na+/K+, Mg2+ATPase activity to obtain only Na+/K+ATPase activity. 
ATPase activities were expressed as µg of inorganic phosphate 
(Pi)/mg of the protein [30].  
Determination of the activities of acetylcholine esterase (AChE) 
and measurement of nitric oxide concentration in RBCs 
The activity of AChE of RBCs of the different experimental groups 
was determined from the suspended membrane fractions of 
hemolyzed RBCs according to the method developed by Ellman et al., 
[31]. Acetylcholine iodide was used as the substrate which when 
acted on by AChE breaks down to thiocholine and acetate. 
Thiocholine is allowed to react with dithiobisnitrobenzoate (DTNB) 
which results in the development of a yellow colour. The changes in 
the intensity of yellow colour over a period were estimated using a 
UV/VIS spectrophotometer, which represents the activity of AChE. 
One tenth of acetylcholine iodide and 0.3 mM DTNB solution was 
prepared in phosphate buffer of pH 7.4 for the assay of the enzyme.  
The concentration of nitric oxide (NO) was measured using Griess 
reagent. (1% sulfanilamide–0.1% N-1-naphthyl-ethylenediamine 
dihydrochloride in 2.5% phosphoric acid) (Sigma, St. Louis, MO, 
USA). Hemolysates were mixed with an equal amount of Griess 
reagent [32]. The generation of NO was determined by measuring 
the absorbance at 540 nm in a spectrophotometer of the purple azo 
compound formed from the reaction between nitrates formed in 
samples and Griess reagent i. e, sulfanilamide and N-
1napthylethylenediamine dihydrochloride (NED). Potassium nitrate 
(Sigma) dilutions, ranging from 0 to 35 mM, were used to create a 
standard curve. Data are presented as the concentration of nitrite 
(mM) per mg protein amount (mg).  
Determination of the activity of methaemoglobin reductase 
(MHbR), measurement of methaemoglobin concentration and 
Heinz body in RBCs 
The activity of MHbR was determined from hemolysate by the 
method adopted by Board et al., [33]. Potassium ferricyanide is 
reduced to potassium ferrocyanide by MHbR and the change in 
absorbance corresponding to the formation of NAD+is measured 
spectrophotometrically at 340 nm. Tris HCl EDTA buffer (pH 8.0) 
was used for the assay.  
Heinz body content was determined in RBCs directly from the 
turbidimetric measurement as adapted by Bates and Winterbourn, 
(1984) [34]. Whole RBCs were incubated with 5 mM sodium 
phosphate buffer, pH 7.4 for 15 min at room temperature, in dark 
and absorbance was recorded spectrophotometrically (Biorad) at 
700 nm. 
Morphological studies of erythrocytes by using Atomic force 
microscopy (AFM)  
Control and the treated whole RBCs were fixed using 3 % 
glutaraldehyde for 30 min and rinsed with phosphate buffered 
saline. The samples were dehydrated with series of ethanol and 
sample was drawn on a glass coverslip to prepare a film. The film 
was then air dried and was ready for AFM analysis. 
AFM imaging and measurement 
AFM study was performed with model Veeco di Innova(Company 
name Bruker) Multimode system. All the images were taken using 
tapping mode in air (ambient temperature) with RTESPA tip silicon 
probes at resonant frequency 276-318 kHz. 100 µm L scanner was 
used. Scan area size is 5 µm X 5 µm. The images obtained were 
analyzed by Nanoscope Software version 1.40 in offline . The 
following parameters were measured:  
The form and the size of RBCs were measured; these measurements 
included 3D image, diameter, radius, concave depth and roughness 
of the erythrocytes. 
Statistical analysis  
Data are presented as means±SEM Significance of mean values of 
different parameters between the treatment groups were analyzed 
using one-way analysis of variances (ANOVA) after ascertaining the 
homogeneity of variances between the treatments. Pairwise 
comparisons were done by calculating the least significance. 
Statistical tests were performed using Microcal Origin version 7.0 
for Windows. 
RESULTS  
Flow cytometry analysis of RBCs exposed to PHZ (1 mM) for 1hour 
exhibited a significant increase by 30.29%;(*P≤ 0.001 vs. control) in 
the intracellular ROS level compared to the control (Fig. 1A, B and 
C). Such intracellular ROS levels were prevented from being 
increased by 20.61%; (**P≤ 0.001vs. PHZ-treated group) 
significantly on co-treatment with aqueous bark extract of TA (5 
mg/ml) and PHZ (1 mM) (Fig. 1). TA itself was not involved in ROS 
generation, as was observed from DCF fluorescence intensity when 









Events % Total FITC-A 
Median
%Changes
CON 1262 4.21 175 175±0.052
T5C 4743 15.81 188 188±0.040
PHZ 11303 37.68 228 228±0.029*





Fig. 1: A, B and C Protective effect of aqueous bark extract of Terminalia arjuna on the ROS scavenging activity in vitro against 
phenylhydrazine-induced oxidative stress in goat RBCs 
CON = Control; T5C = Terminalia arjuna bark extract (5 mg/ml); PHZ=Phenylhydrazine; P+T5= Phenylhydrazine+Terminalia arjuna bark extract (5 
mg/ml); the values are expressed as mean±SE, *P≤0.001 compared to control group; **P≤ 0.001 compared to PHZ treated group using ANOVA. 
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HE is selectively oxidized to ethidium by superoxide, anion free 
radical. The intensity of ethidium fluorescence reflects the level 
of O2·_produced in the cell since O2·_cannot easily transverse the 
cell membrane. As shown in fig. 2A, B and C, the fluorescence 
intensity of the PHZ (1 mM) treated RBCs were increased by 
32.26% (*P≤ 0.001 vs. control), while in RBCs  co-incubated with 
PHZ (1 mM) and aqueous bark extract of TA (5 mg/ml), the 
fluorescence intensity was prevented from being increased by 
21.95 % (**P≤ 0.001vs . PHZ-treated group). However, TA 
aqueous bark extract alone was not involved in superoxide 
radical generation, as was observed from ethidium fluorescence 
intensity in the RBCs. 
 
 
Fig. 2: A, B and C Protective effect of aqueous bark extract of Terminalia arjuna on the superoxide radical scavenging activity in vitro 
against phenylhydrazine-induced oxidative stress in goat RBCs 
CON = Control; T5C = Terminalia arjuna bark extract (5 mg/ml); PHZ=Phenylhydrazine; P+T5= Phenylhydrazine+Terminalia arjuna bark extract 






Fig. 3: Protective effect of aqueous bark extract of Terminalia 
arjuna on: A. Hydroxyl radical scavenging activity in vitro and B. 
intracellular iron concentration, against phenylhydrazine-
induced oxidative stress in goat RBCs 
CON = Control; T5C = Terminalia arjuna bark extract (5 mg/ml); 
PHZ=Phenylhydrazine; P+T5= Phenylhydrazine+Terminalia 
arjuna bark extract (5 mg/ml); the values are expressed as 
mean±SE, *P≤0.001 compared to control group; **P≤ 0.001 
compared to PHZ treated group using ANOVA 
The hydroxyl radical scavenging ability of aqueous TA bark extract 
was studied in an in vitro standard model system using PHZ where 
·OH was generated. fig.  3A indicated that PHZ (1 mM) produced 
about 684 nmoles ·OH per ml incubation mixture in 1hr and aqueous 
bark extract of TA directly scavenged OH· by about 71% (**P≤ 
0.001vs. PHZ-treated group) at a concentration of 5 mg/ml (fig. 3A). 
Fig. 3B demonstrates decreased the intracellular iron concentration 
of RBCs treated with 1 mM PHZ (30.97%; *P≤0.001 vs. control). 
However, when the RBCs were co-incubated with aqueous bark 
extract of TA (5 mg/ml) and PHZ (1 mM), the intracellular iron content 
of RBCs was found to be protected from being decreased by1.21 folds; 
(**P≤0.001 vs. PHZ-treated group). Aqueous TA bark extract alone had 
no significant effect on the concentration of iron in the RBCs. 
Fig. 4A reveals that on the treatment of the RBCs with PHZ, the 
activities of G6PDH, hexokinase and aldolase decreased respectively 
by 40.78 %, 63.79% and 63.31% (*P≤ 0.001 vs. control) and that of 
lactate dehydrogenase (LDH) increased 1.68 folds (*P≤ 0.001 vs. 
control). When the RBCs were co-treated with PHZ (1 mM) and 
aqueous bark extract of TA at a dose of 5 mg/ml, the activities of 
G6PDH, hexokinase and aldolase were found to be significantly 
protected from being decreased by 57.38 %, 1.75 folds, and 1.70 
folds respectively (**P≤0.001 vs. PHZ-treated group) and in case of 
LDH the enzyme activity was significantly protected from being 
increased by 62.30% (**P≤0.001 vs. PHZ-treated group). 
Fig. 4B reveals that treatment of RBCs with PHZ(1 mM) decreased 
the activities of Na+/K+ATPase, Mg2+ATPase, Ca2+ATPase by 42.83%, 
26.15% and 32.64% respectively (*P≤ 0.001 vs. control). Co -
treatment of RBCs with PHZ(1 mM) and aqueous bark extract of TA 
(5 mg/ml) were found to protect the activities of these three 
ATPases from being decreased by 69.55%, 34.19%, and 47.06% 
respectively (**P≤ 0.001 vs . PHZ-treated group). However, TA 
aqueous bark extract alone did not significantly alter the activity of 
any of the enzymes studied. 
Treatment of RBCs with PHZ (1 mM) for 1 hour decreased the AchE 
enzyme activity by 1.55 folds and increased the NO concentration by 
54.87% (*P≤ 0.001 vs. control). The enzyme activity of the AChE and 
Chattopadhyay et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 5, 62-70 
66 
intracellular NO concentration were found to be protected 
significantly from being altered, when the RBCs were co-treated 
with PHZ and 5 mg/ml of the aqueous bark extract of TA (50.29% 
increase in acetylcholine esterase enzyme activity and 1.21 folds 
decrease in intracellular NO concentration, **P≤ 0.001 vs. PHZ -
treated group) (fig. 5A and B). 
 
 
Fig. 4A: Protective effect of aqueous bark extract of 
Terminalia arjuna against PHZ induced changes in activities 
of glucose-6-phosphate dehydrogenase (G6PDH), 
hexokinase, aldolase and lactate dehydrogenase (LDH) of 
goat RBCs 
CON = Control; T5C = Terminalia arjuna bark extract (5 
mg/ml); PHZ=Phenylhydrazine; P+T5= 
Phenylhydrazine+Terminalia arjuna bark extract (5 mg/ml); 
the values are expressed as mean±SE, *P≤0.001 compared to 




Fig. 4B: Protective effect of aqueous bark extract of 
Terminalia arjuna against PHZ induced changes in activities 
of sodium-potassium ATPase (Na+/K+ATPase), magnesium-
ATPase (Mg2+ATPase) and calcium ATPase (Ca2+ATPase) of 
goat RBCs 
CON = Control; T5C = Terminalia arjuna bark extract (5 
mg/ml); PHZ=Phenylhydrazine; P+T5= 
Phenylhydrazine+Terminalia arjuna bark extract (5 mg/ml); 
the values are expressed as mean±SE, *P≤0.001 compared to 
control group; **P≤ 0.001 compared to PHZ treated group 
using ANOVA 
 
Fig. 6 A, B and C illustrates an increase in methaemoglobin 
concentration and turbidity index by 31.18%, 67.21% and a 
significant decrease in methaemoglobin reductase activity of RBCs 
by 58.33% respectively,* P≤ 0.001 vs. control) following exposure of 
RBCs to PHZ (1 mM). However, co-treatment of RBCs with PHZ (1 
mM) and the present dose of aqueous bark extract of TA 
significantly decreased the methaemoglobin concentration as well as 
turbidity index and protected the methaemoglobin reductase 
activity (23.19 %, 36.27% decrease, and 1.42 folds increase 
respectively, **P≤ 0.001 vs. PHZ) from being altered. The results 
indicate that the aqueous bark extract of TA alone has no influence 
on the methaemoglobin concentration, turbidity index, and 





Fig. 5: Protective effect of aqueous bark extract of Terminalia 
arjuna against PHZ induced alterations on A. activity of 
acetylcholine esterase (AChE) and B. nitric oxide concentration 
in goat RBCs 
CON = Control; T5C = Terminalia arjuna bark extract (5 mg/ml); 
PHZ=Phenylhydrazine; P+T5= Phenylhydrazine+Terminalia 
arjuna bark extract (5 mg/ml); the values are expressed as 
mean±SE, *P≤0.001 compared to control group; **P≤ 0.001 
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Fig. 6: Protective effect of aqueous bark extract of Terminalia 
arjuna on A. methaemoglobin concentration, B. 
methaemoglobin reductase activity, and C. turbidity index, 
against phenylhydrazine induced oxidative stress in goat RBCs 
CON = Control; T5C = Terminalia arjuna bark extract (5 mg/ml); 
PHZ=Phenylhydrazine; P+T5= Phenylhydrazine+Terminalia 
arjuna bark extract (5 mg/ml); the values are expressed as 
mean±SE, *P≤0.001 compared to control group; **P≤ 0.001 
compared to PHZ treated group using ANOVA 
Measurement of morphological parameters of RBCs by AFM 
indicated that PHZ treatment altered the shape of RBCs due to an 
increase in the diameter and radius (by 36.76% and 36.06% 
respectively, *P ≤ 0.001 vs. control) and a reduced concave depth 
and roughness (by 36.28% and 46.80% respectively, *P ≤ 0.001 
vs. control) (Fig.7A and B).  
However, co-treatment with PHZ (1 mM) and aqueous bark 
extract of TA (5 mg/ml) protected the RBCs from these 
alterations in diameter, radius, depth, and roughness. 
DISCUSSION 
Phenylhydrazine (PHZ) in the presence of hemoglobin autoxidizes 
to form both superoxide anion free radical and hydrogen peroxide 
which ultimately give rise to hydroxyl radical. In our present 
study, there was a significant increase in the level of ROS 
production in the RBCs following treatment with PHZ (fig. 1A, B 
and C). It was previously reported that PHZ intoxication leads to 
hemolysis resulting in severe hemolytic anemia and generates ROS 
[37]. Our present studies, however, demonstrated that co-
treatment of goat RBCs with PHZ and aqueous bark extract of TA 
at present does prevented the enhancement of ROS production in 












Control 3.40±0.057 1.70±0.058 576±0.087 1579±0.057
T5C 4.01±0.046 2.00±0.046 430±0.029 1269±0.028
PHZ 4.65±0.040* 2.33±0.035* 367±0.058* 840±0.046*












Fig. 7: A and B protective effect of aqueous bark extract of Terminalia arjuna against phenylhydrazine-induced oxidative stress on 
morphological changes of goat RBCs using atomic force microscopy. 1st panel (2D image) 2nd panel (3D image) 3rd-panel measurement 
of diameter, radius, concave depth and roughness (scan area size is 5 µm X 5 µm) of the RBC 
CON = Control; T5C = Terminalia arjuna bark extract (5 mg/ml); PHZ=Phenylhydrazine; P+T5= Phenylhydrazine+Terminalia arjuna bark 
extract (5 mg/ml); the values are expressed as mean±SE, *P≤0.001 compared to control group; **P≤ 0.001 compared to PHZ treated group 
using ANOVA 
 
An elevated level of ·OH is indicative of an elevated level of oxidative 
stress following treatment of goat RBCs with PHZ (fig. 3A). 
Phenylhydrazine in the presence of haemoglobin oxidizes to form 
hydrogen peroxide that generates ·OH through Haber–Weiss 
Reaction [38]. The latter initiates the peroxidation of unsaturated 
fatty acids in endogenous phospholipids [39]. Besides PHZ, other 
oxidants like iron with hydrogen peroxide and hydrogen peroxide 
alone, participates in oxidative reactions through the generation of 
highly reactive. OH this readily damages lipids, proteins and other 
components of the cell membrane. Our studies reveal (fig. 3A) that 
co-treatment of goat RBCs with PHZ and aqueous bark extract of TA 
reduces the amount of· OH formation in the RBCs, demonstrating the 
ability of the extract to reduce the level of oxidative stress. 
Additionally, it has already been reported from our laboratory that 
the aqueous bark extract of TA exhibited a strong hydroxyl radical 
scavenging potential [40]. However, the extract did not exhibit any 
H2O2 scavenging activity and metal ion chelating effect in vitro (40). 
Damaging effects of PHZ like other oxidants have been reported by 
various workers [41]. It has also been demonstrated that normal 
RBCs treated with PHZ has a mimetic characteristic as those found 
in severe β-thalassemia [42]. Phenylhydrazine-induced peroxidation 
of oxyhemoglobin and MHb leads to the formation of both 
superoxide (O-) and phenyl radicals [43]. These radicals can 
denature haemoglobin with the consequential release of iron from 
denatured haemoglobin which can induce lipid peroxidation of the 
cell membrane if the cell is depleted of GSH. This eventually causes 
RBC haemolysis [43]. Increased MHb concentration increased 
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superoxide anion free radicals and decreased the intracellular iron 
concentration of RBCs and increased turbidity index following 
treatment with PHZ indicated elevated levels of oxidative stress (fig. 
6A, fig. 2A, B and C and fig. 6C). The GSH concentrations were found 
to be depleted following PHZ treatment of RBCs in our earlier 
observation [20]. In the present study, co-treatment of RBCs with 
PHZ and aqueous bark extract of TA inhibited MHb formation, 
prevented superoxide anion free radical generation and protected 
the hemoglobin structure thereby reducing the turbidity index 
which prevented the hemolysis of RBCs.  
The present study further reveals that MR activity is decreased 
following treatment of RBCs with PHZ. This results in accumulation 
of MHb in the RBCs (fig. 6A and B respectively.) Co-treatment of 
RBCs with PHZ and aqueous bark extract of TA prevents the rise in 
MHb level. 
The RBCs depend solely on the anaerobic conversion of glucose by 
the Embden-Meyerhof pathway for the generation and storage of 
high energy phosphates, which is necessary for the maintenance of a 
number of vital functions. Fig. 4A shows that the activities of the 
metabolic enzymes G6PDH, hexokinase, aldolase and LDH are 
altered by the treatment of RBCs with PHZ. However, co-treatment 
of the RBCs with aqueous bark extract of TA and PHZ, protected the 
activities of these enzymes from being altered consequently 
protecting the metabolic status of the RBCs. 
Erythrocytes are highly susceptible to oxidative damage due to the 
presence of heme iron. Polyunsaturated fatty acids (PUFA) and 
oxygen may initiate the reactions that induce oxidative changes in 
the red blood cells [44, 45]. Peroxidation of PUFA in membrane 
lipids has been suspected to be a major mechanism of oxidant injury 
leading to membrane dysfunction and subsequently to alterations in 
cellular functions [45,46]. Lipid peroxidation and perturbed lipid 
composition are known to disturb structural integrity of the 
membrane that might, in turn, affect the activity of membrane-
bound enzymes like ATPases [47]. Membrane-bound enzymes are 
important in maintaining the normal physiology of erythrocytes. The 
decrease in the activities of the membrane ATPases in this study 
may be due to the elevation in free radical formation and decrease in 
the GSH content. Free radicals can induce degenerative changes in 
erythrocytes that can affect dynamic properties of the membranes 
such as fluidity and permeability and consequently the activities of 
the membrane-bound enzymes. It has been reported earlier that 
oxidative products inhibit Na+/K+-ATPase and Mg2+-ATPase 
activities [48]. Lipid peroxidation decreases the affinity of Na+/K+-
ATPase for Na+and K+ions because the active sites of these enzymes 
are directly attacked by ROS. It may be suggested that inhibition of 
erythrocyte membrane Na+/K+-ATPase in PHZ treated goat RBCs 
lead to disturbance or impairment of Na+/K+-pump in membrane 
due to alterations in the composition of the erythrocyte membranes, 
which in turn results in decreased activities of other membrane-
bound enzymes. Na+/K+-pump functions for the maintenance of the 
ionic milieu of normal blood cells and essential for the normal 
functioning of the cells. Co-treatment of the RBCs with aqueous bark 
extract of TA and PHZ restored the activities of ATPases to some 
extent. This might be due to the potential role of this aqueous bark 
extract of TA to scavenge the free radicals produced by PHZ-induced 
toxicity.  
The present study demonstrated that in vitro administration of PHZ 
resulted in inhibition of AChE activity in erythrocytes and co-
administration of aqueous bark extract of TA and PHZ helps in 
partial protection of AChE activity. In blood, normal erythrocyte 
function depends on the intactness of the erythrocyte membrane, 
which is the target for PHZ toxicity [43]. Inhibition of AChE activity 
by PHZ is well documented in the literature [49]. In addition to 
inhibition of AChE activity, PHZ has been shown to induce lipid 
peroxidation and oxidative stress in various tissues [50]. The cells 
have several ways to alleviate the effects of oxidative stress either by 
repairing the oxidative damage or by directly diminishing the 
occurrence of oxidative damage by means of enzymatic and non-
enzymatic antioxidants which have been shown to scavenge free 
radicals and ROS [51]. Numerous reports have documented 
protective actions of aqueous bark extract of TA in various models of 
oxidative stress due to its high efficacy as a free radical scavenger 
and indirect antioxidant [20, 40, 52]. It has been reported that 
aqueous bark extract of TA also directly neutralizes the precursor of 
•OH, namely hydrogen peroxide [40]. The •OH is widely accepted as 
the most damaging molecule endogenously produced in aerobic 
organisms, and many studies have confirmed the TA’s ability to 
detoxify •OH [53, 54]. The •OH mutilates any molecule in the vicinity 
of where it is produced [55]. Exogenous administration of aqueous 
TA bark extract neutralized the formation of ROS, reducing thereby, 
the molecular and physiological damage. In addition, increased 
intracellular level of NO in PHZ treated RBCs were observed. 
Increased concentration of NO has been reported to cause 
accumulation of nitrite, an end product of nitric oxide metabolism, 
which reacts with superoxide radicals ultimately leading to 
nitrosative stress [56]. Co-treatment of RBCs with PHZ and aqueous 
bark extract of TA prevented this increase in NO concentration 
thereby indicating once again TA’s ability to provide protection 
against oxidative insult. The aqueous bark extract of TA also reduces 
the generation of NO by inhibiting the activity of its rate limiting 
enzyme, nitric oxide synthase (NOS) [57].  
Atomic force microscopy (AFM) is an advanced tool to analyze the 
structure of the erythrocyte membrane and its membrane proteins 
[58]. In our previous studies, it was observed that PHZ altered the 
RBC membrane structure by causing an alteration in the membrane 
protein content [20]. In our current study, the diameter, radius, 
concave depth and roughness of the RBCs were measured with the 
help of AFM analysis. With PHZ treatment, the structure of RBCs was 
altered; concave depth and roughness were also decreased (fig. 7A 
and B). On the contrary, simultaneous treatment of RBCs with 
aqueous bark extract of TA and PHZ protected the RBCs from these 
morphological alterations (fig. 7A and B). 
CONCLUSION 
Thus, it can be concluded from the above findings that PHZ at the 
present dose triggered oxidative stress-induced morphologic and 
metabolic alterations and functional impairment in the goat red 
blood cells. The aqueous bark extract of TA is capable of providing 
protection against these PHZ induced oxidative stress mediated 
alterations in the RBCs possibly through its antioxidant mechanisms. 
The results of the present study hints at the possibility that the 
aqueous bark extract of TA with the promising antioxidant potential 
to combat oxidative stress-induced damages may have future 
therapeutic relevance in situations of hemolytic anemia and other 
diseases involving oxidative stress in general. 
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